The geminal dimethyl analogue of Flurbiprofen as a novel Aβ42 inhibitor and potential Alzheimer’s disease modifying agent
- 15 April 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (8), 2219-2223
- https://doi.org/10.1016/j.bmcl.2006.01.033
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inhibition of Noxious Stimulus-Induced Spinal Prostaglandin E2 Release by Flurbiprofen EnantiomersJournal of Neurochemistry, 2008
- Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-l-alaninamide]Journal of Pharmacology and Experimental Therapeutics, 2005
- Selected Non-steroidal Anti-inflammatory Drugs and Their Derivatives Target γ-Secretase at a Novel SiteJournal of Biological Chemistry, 2004
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of actionJournal of Neurochemistry, 2004
- Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptidesPeptides, 2002
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Human Plasma Concentrations of R, S, and Racemic Flurbiprofen Given as a ToothpasteThe Journal of Clinical Pharmacology, 1996
- Variability of inversion of (R)‐flurbiprofen in different speciesJournal of Pharmaceutical Sciences, 1992
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992
- Stereoselective disposition of ibuprofen and flurbiprofen in ratsChirality, 1990